OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab

NCT01243086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Ranibizumab
DRUG: OZURDEX

Sponsor

McMaster University

Collaborators

[object Object]
[object Object]